Skip to main content
Torrent Pharmaceuticals Ltd. logo

Torrent Pharmaceuticals Ltd. — Investor Relations & Filings

Ticker · TORNTPHARM ISIN · INE685A01028 LEI · 335800NA6HK275RIJE13 BSE.NS Manufacturing
Open in API
Filings indexed 1,765 across all filing types
Latest filing 2021-08-06 Regulatory Filings
Country IN India
Listing BSE.NS TORNTPHARM

About Torrent Pharmaceuticals Ltd.

https://www.torrentpharma.com

Torrent Pharmaceuticals Ltd. is a research-driven organization focused on the development, manufacturing, and marketing of generic formulations. The company holds a significant position in therapeutic areas such as cardiovascular, central nervous system, gastrointestinal, diabetology, and anti-infective treatments. It has strategically expanded its portfolio into dermatology, nephrology, and pain management through targeted acquisitions. The firm operates across multiple international markets, supported by advanced research and development centers and manufacturing facilities that adhere to global regulatory standards. Its core operations prioritize chronic therapy leadership and the provision of high-quality healthcare solutions through a robust pipeline of generic and value-added medicines.

Recent filings

Filing Released Lang Actions
Loss of Share Certificates
Regulatory Filings Classification · 85% confidence The document contains tabular data listing shareholders, their folio numbers, number of shares, certificate numbers, and distinctive share numbers. There is no indication of a report, announcement, or narrative text. The content appears to be a notification or record related to shareholdings, but it does not specify changes in major shareholding levels crossing thresholds, nor does it indicate a formal announcement of such changes. Given the lack of context and the nature of the data, this document does not fit neatly into categories like Major Shareholding Notification (MRQ) or Share Issue/Capital Change (SHA). It is more consistent with a general regulatory filing or miscellaneous shareholder information. The document is short and does not reference any report or meeting results. Therefore, the best fit is Regulatory Filings (RNS), which serves as a fallback for miscellaneous filings that do not fit other categories.
2021-08-06 English
Intimation of Loss of Share Certificate
Regulatory Filings Classification · 95% confidence The document is an official communication from Torrent Pharmaceuticals Limited to stock exchanges (BSE and NSE) regarding the loss of a share certificate by a shareholder. It includes details of the lost certificate and a request to trading members to refrain from trading those shares. The document also encloses a letter from the Registrar and Transfer Agent (RTA) confirming receipt of the loss information. This is a regulatory disclosure related to share certificate loss and does not contain financial data, earnings, management discussion, or other report content. It is a regulatory announcement informing the exchanges and market participants about the lost share certificate and the issuance of a duplicate. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2021-08-04 English
Loss of Share Certificates
Regulatory Filings Classification · 95% confidence The document is an official communication from Torrent Pharmaceuticals Limited to stock exchanges (BSE and NSE) regarding the loss of a share certificate by a shareholder. It includes details of the lost certificate and a request to trading members to refrain from trading those shares. The document also encloses a letter from the Registrar and Transfer Agent (RTA) confirming receipt of the loss information. This is a regulatory compliance notification under SEBI Listing Obligations and Disclosure Requirements, specifically about share certificate loss and duplicate issuance. It is not a financial report, earnings release, or management discussion. It is also not a voting result, capital change, or director dealing. The document is a regulatory announcement informing the market and exchanges about a specific event related to share certificates. Therefore, it fits best under Regulatory Filings (RNS). The document length is under 5,000 characters and is a direct notification, not a report publication announcement or certification letter. Confidence is high due to clear regulatory context and content.
2021-08-04 English
Updates
Regulatory Filings Classification · 95% confidence The document is an intimation under Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, which pertains to disclosure of material events or information by listed companies. The content describes the completion of acquisition transactions involving shareholding percentages and purchase considerations. There is no detailed financial report, earnings data, or management discussion. The document is a regulatory announcement informing stock exchanges about a significant acquisition event. It is not a full report, audit, or earnings release, nor is it a voting result or board change notice. Given the nature of the disclosure and the regulatory context, this fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories. The document length is under 5,000 characters and is a formal notification to exchanges, not a report itself.
2021-07-31 English
Intimation under Regulation 30 of SEBI (Listing Obligation and Disclosures Requirements) Regulations, 2015, ("Listing Regulations")
Regulatory Filings Classification · 95% confidence The document is an intimation under Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, which pertains to disclosure of material events or information by listed companies. The content describes the completion of acquisition transactions involving shareholding percentages and purchase considerations. There is no detailed financial report, earnings data, or management discussion. The document is a regulatory announcement informing stock exchanges about a significant acquisition event. It is not a full report, audit, or earnings release, nor is it a voting result or board change announcement. Given the nature of the disclosure and the regulatory context, this fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories. The document length is under 5,000 characters and is a formal notification to exchanges, not a report itself.
2021-07-31 English
Shareholders meeting
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a detailed declaration of voting results from the 48th Annual General Meeting (AGM) of Torrent Pharmaceuticals Limited held on 27th July 2021. It includes voting outcomes on various resolutions such as adoption of financial statements, dividend declarations, director appointments, and remuneration approvals. The text references compliance with the Companies Act, 2013, SEBI regulations, and includes a consolidated report of the scrutinizer on remote e-voting and e-voting at the AGM. The content is focused on the official results of shareholder votes at the AGM, not the AGM materials themselves or the annual report. Therefore, the document fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA). The document length and detail confirm it is not a brief announcement or a report publication notice, but the actual declaration of voting results.
2021-07-28 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.